Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

CR-2017 improves intestinal activity/tolerance in functional gut disorders patients

May 18, 2010

Phase II safety/efficacy data on anti-IP-10 antibody in subjects with active UC presented

May 18, 2010

LA-480 inhibits HGF-dependent and independent c-Met signaling in preclinical study

May 18, 2010

ArQule presents preclinical data on novel Raf kinase B and C inhibitors

May 18, 2010

Low efficacy seen with FMP2.1/AS02A malaria vaccine in children

May 18, 2010

AIN-457 evaluated in clinical studies in patients with noninfectious uveitis

May 18, 2010

Novel Erk/PI3K inhibitors with potent preclinical activity described by AEterna Zentaris

May 18, 2010

Promising phase II data on JX-594 in HCC support phase III evaluation

May 17, 2010

VAX-102 increases immune response to trivalent influenza vaccine

May 17, 2010

Presidio reports preclinical data on its novel HCV NS5A inhibitor PPI-461

May 17, 2010

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...